famotidine

Generic: famotidine

Labeler: lannett company, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name famotidine
Generic Name famotidine
Labeler lannett company, inc.
Dosage Form POWDER, FOR SUSPENSION
Routes
ORAL
Active Ingredients

famotidine 40 mg/5mL

Manufacturer
Lannett Company, Inc.

Identifiers & Regulatory

Product NDC 0527-5190
Product ID 0527-5190_4aedf984-0009-404b-8c21-8af5f225f9db
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA217982
Listing Expiration 2026-12-31
Marketing Start 2025-06-02

Pharmacologic Class

Established (EPC)
histamine-2 receptor antagonist [epc]
Mechanism of Action
histamine h2 receptor antagonists [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 05275190
Hyphenated Format 0527-5190

Supplemental Identifiers

RxCUI
310274
UNII
5QZO15J2Z8
NUI
N0000000151 N0000175784

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name famotidine (source: ndc)
Generic Name famotidine (source: ndc)
Application Number ANDA217982 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 40 mg/5mL
source: ndc
Packaging
  • 55 mL in 1 BOTTLE (0527-5190-80)
source: ndc

Packages (1)

0527-5190-80 55 mL in 1 BOTTLE (0527-5190-80)

Ingredients (1)

famotidine (40 mg/5mL)

Linked Drug Pages (1)

Famotidine ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "4aedf984-0009-404b-8c21-8af5f225f9db", "openfda": {"nui": ["N0000000151", "N0000175784"], "unii": ["5QZO15J2Z8"], "rxcui": ["310274"], "spl_set_id": ["7e0da8be-b001-400e-99d1-37f335b1d7b3"], "pharm_class_epc": ["Histamine-2 Receptor Antagonist [EPC]"], "pharm_class_moa": ["Histamine H2 Receptor Antagonists [MoA]"], "manufacturer_name": ["Lannett Company, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "55 mL in 1 BOTTLE (0527-5190-80)", "package_ndc": "0527-5190-80", "marketing_start_date": "20250602"}], "brand_name": "Famotidine", "product_id": "0527-5190_4aedf984-0009-404b-8c21-8af5f225f9db", "dosage_form": "POWDER, FOR SUSPENSION", "pharm_class": ["Histamine H2 Receptor Antagonists [MoA]", "Histamine-2 Receptor Antagonist [EPC]"], "product_ndc": "0527-5190", "generic_name": "Famotidine", "labeler_name": "Lannett Company, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Famotidine", "active_ingredients": [{"name": "FAMOTIDINE", "strength": "40 mg/5mL"}], "application_number": "ANDA217982", "marketing_category": "ANDA", "marketing_start_date": "20250602", "listing_expiration_date": "20261231"}